DEXTROSE — all Canadian products
254 DINs
67 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DEXTROSE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 00438014 | (20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 3.3 G; SODIUM CHLORIDE 300 MG; POTASSIUM CHLORIDE 150 MG | Marketed | |
| 00786292 | (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 900 MG; POTASSIUM CHLORIDE 150 MG | Marketed | |
| 00438049 | (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; POTASSIUM CHLORIDE 150 MG | Marketed | |
| 00437999 | (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 450 MG; POTASSIUM CHLORIDE 150 MG | Marketed | |
| 00438030 | (40 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; POTASSIUM CHLORIDE 300 MG | Marketed | |
| 00438022 | (40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 3.3 G; SODIUM CHLORIDE 300 MG; POTASSIUM CHLORIDE 300 MG | Marketed | |
| 00438006 | (40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 450 MG; POTASSIUM CHLORIDE 300 MG | Marketed | |
| 01931598 | 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 200 MG; POTASSIUM CHLORIDE 150 MG | Marketed | |
| 01924427 | 10% DEXTROSE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 100 MG | Marketed | |
| 00060364 | 10% DEXTROSE INJECTION, USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 10 G | Marketed | |
| 01927531 | 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 450 MG | Marketed | |
| 01924435 | 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 50 MG; SODIUM CHLORIDE 9 MG | Marketed | |
| 01924281 | 5% DEXTROSE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 50 MG | Marketed | |
| 00060348 | 5% DEXTROSE INJECTION, USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G | Marketed | |
| 02014874 | 70% DEXTROSE INJECTION USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 70 G | Marketed | |
| 02516179 | 70% DEXTROSE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 70 G | Approved | |
| 00788139 | ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A | FRESENIUS KABI AG | Solution | Extracorporeal | DEXTROSE 2.45 G; SODIUM CITRATE 2.2 G; CITRIC ACID 730 MG | Marketed | |
| 02516675 | ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A | FRESENIUS KABI AG | Solution | Extracorporeal | DEXTROSE 2.54 G; SODIUM CITRATE 2.14 G; CITRIC ACID 770 MG | Approved | |
| 02401401 | AVL DEXTROSE SOLUTION 50% | ALBERTA VETERINARY LABORATORIES LTD | Solution | Intravenous; Intraperitoneal | DEXTROSE 50 % | Marketed | |
| 02242113 | CALF-LYTE II | VETOQUINOL N A INC | Powder For Solution | Oral | DEXTROSE 41.734 G; SODIUM CHLORIDE 3.507 G; GLYCINE 6.756 G; POTASSIUM CHLORIDE 1.940 G; SODIUM ACETATE 13.125 G; SODIUM PHOSPHATE MONOBASIC 0.600 G; POTASSIUM PHOSPHATE DIBASIC 0.349 G; CALCIUM D-PANTOTHENATE 0.012 G | Marketed | |
| 02242114 | CALF-LYTE II HE | VETOQUINOL N A INC | Powder For Solution | Oral | DEXTROSE 149.04 G; SODIUM CHLORIDE 3.507 G; GLYCINE 6.756 G; POTASSIUM CHLORIDE 1.940 G; SODIUM ACETATE 13.127 G; SODIUM PHOSPHATE DIBASIC 0.600 G; POTASSIUM PHOSPHATE DIBASIC 0.349 G; CALCIUM D-PANTOTHENATE 0.012 G | Marketed | |
| 02495767 | CALF-QUENCH | DOMINION VETERINARY LABORATORIES LTD. | Powder For Solution | Oral | DEXTROSE 41.734 G; SODIUM CHLORIDE 3.507 G; GLYCINE 6.756 G; POTASSIUM CHLORIDE 1.94 G; SODIUM ACETATE 13.125 G; SODIUM PHOSPHATE MONOBASIC 0.6 G; POTASSIUM PHOSPHATE DIBASIC 0.349 G; CALCIUM D-PANTOTHENATE 0.012 G | Approved | |
| 02495775 | CALF-QUENCH HE | DOMINION VETERINARY LABORATORIES LTD. | Powder For Solution | Oral | DEXTROSE 149.04 G; SODIUM CHLORIDE 3.507 G; GLYCINE 6.756 G; POTASSIUM CHLORIDE 1.94 G; SODIUM ACETATE 13.127 G; SODIUM PHOSPHATE MONOBASIC 0.6 G; POTASSIUM PHOSPHATE DIBASIC 0.349 G; CALCIUM D-PANTOTHENATE 0.012 G | Marketed | |
| 02453045 | CANEAL PERITONEAL DIALYSIS SOLUTION | CHIEF MEDICAL SUPPLIES LTD | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 4.25 G; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 18.3 MG; MAGNESIUM CHLORIDE 5.08 MG | Approved | |
| 02453010 | CANEAL PERITONEAL DIALYSIS SOLUTION | CHIEF MEDICAL SUPPLIES LTD | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 1.5 G; SODIUM CHLORIDE 567 MG; SODIUM LACTATE 392 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 15.2 MG | Approved | |
| 02453029 | CANEAL PERITONEAL DIALYSIS SOLUTION | CHIEF MEDICAL SUPPLIES LTD | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 4.25 G; SODIUM CHLORIDE 567 MG; SODIUM LACTATE 392 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 15.2 MG | Approved | |
| 02473747 | CANEAL PERITONEAL DIALYSIS SOLUTION | CHIEF MEDICAL SUPPLIES LTD | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 2500 MG; SODIUM CHLORIDE 567 MG; SODIUM LACTATE 392 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 15.2 MG | Approved | |
| 02453037 | CANEAL PERITONEAL DIALYSIS SOLUTION | CHIEF MEDICAL SUPPLIES LTD | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 1.5 G; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 18.3 MG; MAGNESIUM CHLORIDE 5.08 MG | Approved | |
| 02013886 | CLINIMIX | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; L-LEUCINE HYDROCHLORIDE 310 MG; L-PHENYLALANINE HYDROCHLORIDE 310 MG; L-LYSINE HYDROCHLORIDE 290 MG; METHIONINE 290 MG; L-ALANINE 1.04 G; GLYCINE 1.04 G; L-ARGININE 520 MG; L-ISOLEUCINE 240 MG; L-VALINE 230 MG; HISTIDINE 220 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-PROLINE 210 MG; L-TYROSINE 20 MG | Marketed | |
| 02013940 | CLINIMIX | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 20 G; L-LEUCINE HYDROCHLORIDE 310 MG; L-PHENYLALANINE HYDROCHLORIDE 310 MG; L-LYSINE HYDROCHLORIDE 290 MG; METHIONINE 290 MG; L-ALANINE 1.04 G; GLYCINE 1.04 G; L-ARGININE 520 MG; L-ISOLEUCINE 240 MG; L-VALINE 230 MG; HISTIDINE 220 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-PROLINE 210 MG; L-TYROSINE 20 MG | Marketed | |
| 02013932 | CLINIMIX | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 10 G; L-LEUCINE HYDROCHLORIDE 310 MG; L-PHENYLALANINE HYDROCHLORIDE 310 MG; L-LYSINE HYDROCHLORIDE 290 MG; METHIONINE 290 MG; L-ALANINE 1.04 G; GLYCINE 1.04 G; L-ARGININE 520 MG; L-ISOLEUCINE 240 MG; L-VALINE 230 MG; HISTIDINE 220 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-PROLINE 210 MG; L-TYROSINE 20 MG | Marketed | |
| 02014076 | CLINIMIX E | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 10 G; L-LEUCINE HYDROCHLORIDE 310 MG; L-PHENYLALANINE HYDROCHLORIDE 310 MG; L-LYSINE HYDROCHLORIDE 290 MG; METHIONINE 290 MG; L-ALANINE 1.04 G; GLYCINE 1.04 G; L-ARGININE 520 MG; L-ISOLEUCINE 240 MG; L-VALINE 230 MG; HISTIDINE 220 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-PROLINE 210 MG; L-TYROSINE 20 MG; SODIUM ACETATE 205 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 58.5 MG; MAGNESIUM CHLORIDE 24 MG | Marketed | |
| 02142384 | CLINIMIX E | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 10 G; L-LEUCINE 365 MG; L-PHENYLALANINE 280 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 290 MG; METHIONINE 200 MG; L-ISOLEUCINE 300 MG; L-VALINE 290 MG; HISTIDINE 240 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-ALANINE 1.04 G; L-ARGININE 575 MG; L-PROLINE 340 MG; SERINE 250 MG; GLYCINE 515 MG; L-TYROSINE 20 MG; SODIUM ACETATE 205 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 58.5 MG; MAGNESIUM CHLORIDE 24 MG | Marketed | |
| 00783641 | DEXTROSE 0.2% AND 0.9% SOD CHLOR SOLUTION | BAXTER CORPORATION | Solution | Irrigation | DEXTROSE 200 MG; SODIUM CHLORIDE 900 MG | Marketed | |
| 00060755 | DEXTROSE 10% AND 0.9% SOD CHLORIDE INJ | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 10 G; SODIUM CHLORIDE 900 MG | Marketed | |
| 00060712 | DEXTROSE 3.3% AND 0.3% SOD CHLORIDE INJ | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 3.3 G; SODIUM CHLORIDE 300 MG | Marketed | |
| 00060704 | DEXTROSE 5% AND 0.2% SOD CHLORIDE INJ | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 200 MG | Marketed | |
| 00060739 | DEXTROSE 5% AND 0.45% SOD CHLORIDE INJ | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 450 MG | Marketed | |
| 00060747 | DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 900 MG | Marketed | |
| 00467618 | DEXTROSE 50% STERILE INJECTION | BIMEDA-MTC ANIMAL HEALTH INC | Solution | Intravenous; Intraperitoneal | DEXTROSE 50 % | Marketed | |
| 02517132 | DEXTROSE INJECTION | OMEGA LABORATORIES LIMITED | Solution | Intravenous | DEXTROSE 50 % | Marketed | |
| 02468514 | DEXTROSE INJECTION USP | PFIZER CANADA ULC | Solution | Intravenous | DEXTROSE 500 MG | Marketed | |
| 02468506 | DEXTROSE INJECTION USP | PFIZER CANADA ULC | Solution | Intravenous | DEXTROSE 50 MG | Approved | |
| 00037915 | DEXTROSE INJECTION USP | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 50 MG | Marketed | |
| 00799793 | DIANEAL PD101 CAPD SOLUTION WITH 0.5% DEXTROSE | VANTIVE ULC | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 500 MG; SODIUM CHLORIDE 567 MG; SODIUM LACTATE 392 MG; CALCIUM CHLORIDE 23.9 MG; MAGNESIUM CHLORIDE 15.2 MG | Marketed | |
| 00799815 | DIANEAL PD101 CAPD SOLUTION WITH 1.5% DEXTROSE | VANTIVE ULC | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 1.5 G; SODIUM CHLORIDE 567 MG; SODIUM LACTATE 392 MG; CALCIUM CHLORIDE 23.9 MG; MAGNESIUM CHLORIDE 15.2 MG | Marketed | |
| 00799823 | DIANEAL PD101 CAPD SOLUTION WITH 2.5% DEXTROSE | VANTIVE ULC | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 2.5 G; SODIUM CHLORIDE 567 MG; SODIUM LACTATE 392 MG; CALCIUM CHLORIDE 23.9 MG; MAGNESIUM CHLORIDE 15.2 MG | Marketed | |
| 00799807 | DIANEAL PD101 CAPD SOLUTION WITH 4.25% DEXTROSE | VANTIVE ULC | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 4.25 G; SODIUM CHLORIDE 567 MG; SODIUM LACTATE 392 MG; CALCIUM CHLORIDE 23.9 MG; MAGNESIUM CHLORIDE 15.2 MG | Marketed | |
| 00865095 | DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM | VANTIVE ULC | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 1.5 G; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 18.3 MG; MAGNESIUM CHLORIDE 5.08 MG | Marketed | |
| 00865109 | DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM | VANTIVE ULC | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 2.5 G; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 18.3 MG; MAGNESIUM CHLORIDE 5.08 MG | Marketed | |
| 00865117 | DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM | VANTIVE ULC | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 4.25 G; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 18.3 MG; MAGNESIUM CHLORIDE 5.08 MG | Marketed | |
| 02420880 | DMVÉT DEXTROSE 50% | DMVET INC | Solution | Intravenous; Intraperitoneal | DEXTROSE 50 % | Marketed | |
| 02413892 | HEMOSATE ULTRA HS1125 | CHIEF MEDICAL SUPPLIES LTD | Solution | Haemodialysis | DEXTROSE 49.5 G; CITRIC ACID 6.91 G; SODIUM ACETATE 1.11 G; SODIUM CHLORIDE 263 G; POTASSIUM CHLORIDE 3.35 G; CALCIUM CHLORIDE 6.24 G; MAGNESIUM CHLORIDE 2.14 G | Marketed | |
| 00061131 | LACTATED RINGER'S AND 5% DEXTROSE INJECTION, USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 600 MG; SODIUM LACTATE 310 MG; POTASSIUM CHLORIDE 30 MG; CALCIUM CHLORIDE 20 MG | Marketed | |
| 02247721 | PHYSIONEAL 40 GLUCOSE 1.36% | VANTIVE ULC | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 37.5 G; CALCIUM CHLORIDE 0.507 G; MAGNESIUM CHLORIDE 0.14 G; SODIUM CHLORIDE 8.43 G; SODIUM BICARBONATE 3.29 G; SODIUM LACTATE 2.63 G | Marketed | |
| 02368730 | PHYSIONEAL 40 GLUCOSE 1.36% CLEAR-FLEX | VANTIVE ULC | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 18.2 G; CALCIUM CHLORIDE 0.245 G; MAGNESIUM CHLORIDE 0.068 G; SODIUM CHLORIDE 19.95 G; SODIUM BICARBONATE 9.29 G; SODIUM LACTATE 6.73 G | Marketed | |
| 02247722 | PHYSIONEAL 40 GLUCOSE 2.27% | VANTIVE ULC | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 62.6 G; CALCIUM CHLORIDE 0.507 G; MAGNESIUM CHLORIDE 0.14 G; SODIUM CHLORIDE 8.43 G; SODIUM BICARBONATE 3.29 G; SODIUM LACTATE 2.63 G | Marketed | |
| 02247723 | PHYSIONEAL 40 GLUCOSE 3.86% | VANTIVE ULC | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 106.5 G; CALCIUM CHLORIDE 0.507 G; MAGNESIUM CHLORIDE 0.14 G; SODIUM CHLORIDE 8.43 G; SODIUM BICARBONATE 3.29 G; SODIUM LACTATE 2.63 G | Marketed | |
| 02368749 | PHYSIONEAL 40 GLUCOSE 3.86% CLEAR-FLEX | VANTIVE ULC | Solution | Haemodialysis (Intraperitoneal) | DEXTROSE 51.5 G; CALCIUM CHLORIDE 0.245 G; MAGNESIUM CHLORIDE 0.068 G; SODIUM CHLORIDE 19.95 G; SODIUM BICARBONATE 9.29 G; SODIUM LACTATE 6.73 G | Marketed | |
| 00786306 | POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 900 MG; POTASSIUM CHLORIDE 300 MG | Marketed | |
| 02020939 | SCLERODEX | OMEGA LABORATORIES LIMITED | Liquid | Intravenous | DEXTROSE 250 MG; SODIUM CHLORIDE 100 MG | Marketed | |
| 02501813 | SMOFKABIVEN EXTRA NITROGEN | FRESENIUS KABI CANADA LTD | Emulsion | Intravenous | DEXTROSE 8.5 G; SOYBEAN OIL 0.87 G; MEDIUM CHAIN TRIGLYCERIDES (MCT) 0.87 G; OLIVE OIL 0.72 G; FISH OIL 0.43 G; LYSINE (LYSINE ACETATE) 0.43 G; PHENYLALANINE 0.33 G; LEUCINE 0.48 G; VALINE 0.41 G; THREONINE 0.29 G; METHIONINE 0.28 G; ISOLEUCINE 0.33 G; TRYPTOPHAN 0.13 G; ALANINE 0.92 G; ARGININE 0.79 G; GLYCINE 0.72 G; PROLINE 0.73 G; HISTIDINE 0.2 G; SERINE 0.43 G; TAURINE 0.065 G; TYROSINE 0.026 G; SODIUM ACETATE 0.16 G; POTASSIUM CHLORIDE 0.23 G; SODIUM GLYCEROPHOSPHATE 0.23 G; MAGNESIUM SULFATE 0.061 G; CALCIUM CHLORIDE 0.028 G; ZINC SULFATE HEPTAHYDRATE 0.00066 G | Marketed | |
| 02501775 | SMOFKABIVEN EXTRA NITROGEN ELECTROLYTE FREE | FRESENIUS KABI CANADA LTD | Emulsion | Intravenous | DEXTROSE 8.5 G; SOYBEAN OIL 0.87 G; MEDIUM CHAIN TRIGLYCERIDES (MCT) 0.87 G; OLIVE OIL 0.72 G; FISH OIL 0.43 G; LYSINE (LYSINE ACETATE) 0.43 G; PHENYLALANINE 0.33 G; LEUCINE 0.48 G; VALINE 0.41 G; THREONINE 0.29 G; METHIONINE 0.28 G; ISOLEUCINE 0.33 G; TRYPTOPHAN 0.13 G; ALANINE 0.92 G; ARGININE 0.79 G; GLYCINE 0.72 G; PROLINE 0.73 G; HISTIDINE 0.2 G; SERINE 0.43 G; TAURINE 0.65 G; TYROSINE 0.26 G | Marketed | |
| 02542412 | SOLYTES POWDER | ALBERTA VETERINARY LABORATORIES LTD | Powder For Solution | Oral | DEXTROSE 41.734 G; GLYCINE 6.756 G; POTASSIUM CHLORIDE 1.94 G; SODIUM PHOSPHATE MONOBASIC 0.6 G; SODIUM CHLORIDE 3.507 G; CALCIUM D-PANTOTHENATE 0.012 G; POTASSIUM PHOSPHATE DIBASIC 0.349 G; SODIUM ACETATE 13.125 G | Approved | |
| 02047519 | V-LYTES (WATER SOLUBLE ELECTROLYTE POWDER) | VETOQUINOL N A INC | Powder For Solution | Oral | DEXTROSE 47.562 G; SODIUM ACETATE 13.125 G; GLYCINE 6.006 G; SODIUM CHLORIDE 4.675 G; POTASSIUM PHOSPHATE DIBASIC 1.742 G; POTASSIUM CHLORIDE 1.491 G; CITRIC ACID 1.000 G | Marketed | |
| 01957341 | V-LYTES HE (WATER SOLUBLE NUTRIENT, ELECTROLYTE POWDER FOR ORAL USE IN CALVES) | VETOQUINOL N A INC | Powder For Solution | Oral | DEXTROSE 149.924 G; GLYCINE 6.006 G; SODIUM ACETATE 13.125 G; SODIUM CHLORIDE 4.675 G; POTASSIUM PHOSPHATE DIBASIC 1.742 G; POTASSIUM CHLORIDE 1.491 G; CITRIC ACID 1.000 G | Marketed | |
| 02426536 | VETALYTE | DMVET INC | Solution | Intravenous | DEXTROSE 25.0 MG; SORBITOL 25.0 MG; SODIUM LACTATE 7.87 MG; SODIUM CHLORIDE 4.8 MG; POTASSIUM CHLORIDE 0.74 MG; MAGNESIUM CHLORIDE 0.42 MG; CALCIUM CHLORIDE 0.38 MG | Marketed | |
| 00503142 | (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.2% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 200 MG; POTASSIUM CHLORIDE 150 MG | Cancelled Post Market | |
| 01931741 | 0.15% POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.30% SODIUM CHLORIDE INJECTION | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 3.3 G; SODIUM CHLORIDE 300 MG; POTASSIUM CHLORIDE 150 MG | Cancelled Post Market | |
| 01931601 | 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.33% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | Liquid | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 330 MG; POTASSIUM CHLORIDE 150 MG | Cancelled Post Market | |
| 01931547 | 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 450 MG; POTASSIUM CHLORIDE 150 MG | Cancelled Post Market | |
| 01931644 | 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 900 MG; POTASSIUM CHLORIDE 150 MG | Cancelled Post Market | |
| 01931539 | 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 5 G; POTASSIUM CHLORIDE 150 MG | Cancelled Post Market | |
| 01931571 | 0.30% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 450 MG; POTASSIUM CHLORIDE 300 MG | Cancelled Post Market | |
| 01927922 | 10% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 10 G; SODIUM CHLORIDE 900 MG | Cancelled Post Market | |
| 02014823 | 10% DEXTROSE INJECTION, USP | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 10 G | Cancelled Post Market | |
| 02003694 | 100GM GLUCOSE TOLERANCE DRINK | CRITERION SCIENCES | Liquid | Oral | DEXTROSE 10 G | Cancelled Post Market | |
| 02015072 | 13.3% DEXTROSE INJECTION, USP | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 13.3 G | Cancelled Post Market | |
| 02143267 | 2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 10 G; L-LEUCINE 182.5 MG; L-PHENYLALANINE 140 MG; L-LYSINE (L-LYSINE HYDROCHLORIDE) 145 MG; METHIONINE 100 MG; L-ISOLEUCINE 150 MG; L-VALINE 145 MG; HISTIDINE 120 MG; L-THREONINE 105 MG; TRYPTOPHAN 45 MG; L-ALANINE 520 MG; L-ARGININE 290 MG; L-PROLINE 170 MG; SERINE 125 MG; GLYCINE 260 MG; L-TYROSINE 10 MG; SODIUM ACETATE 170 MG; POTASSIUM PHOSPHATE DIBASIC 130.5 MG; SODIUM CHLORIDE 29.3 MG; MAGNESIUM CHLORIDE 25.5 MG | Cancelled Post Market | |
| 02013975 | 2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE CLINIMIX | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 10 G; L-LEUCINE HYDROCHLORIDE 155 MG; L-PHENYLALANINE HYDROCHLORIDE 155 MG; L-LYSINE HYDROCHLORIDE 145 MG; METHIONINE 145 MG; L-ALANINE 520 MG; GLYCINE 520 MG; L-ARGININE 260 MG; L-ISOLEUCINE 120 MG; L-VALINE 115 MG; HISTIDINE 110 MG; L-THREONINE 105 MG; TRYPTOPHAN 45 MG; L-PROLINE 105 MG; L-TYROSINE 10 MG; SODIUM ACETATE 170 MG; POTASSIUM PHOSPHATE DIBASIC 130.5 MG; SODIUM CHLORIDE 29.3 MG; MAGNESIUM CHLORIDE 25.5 MG | Cancelled Post Market | |
| 02014106 | 2.5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 10% DEXTROSE QUICKMIX | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 10 G; L-LEUCINE HYDROCHLORIDE 155 MG; L-PHENYLALANINE HYDROCHLORIDE 155 MG; L-LYSINE HYDROCHLORIDE 195 MG; METHIONINE 195 MG; L-ALANINE 520 MG; GLYCINE 520 MG; L-ARGININE 260 MG; L-ISOLEUCINE 120 MG; L-VALINE 115 MG; HISTIDINE 110 MG; L-THREONINE 105 MG; TRYPTOPHAN 45 MG; L-PROLINE 105 MG; L-TYROSINE 10 MG | Cancelled Post Market | |
| 02143259 | 2.5%TRAVASOL AMINO ACID INJ.W.ELEC.W.25%DEX | CLINTEC NUTRITION COMPANY | Liquid | Intravenous | DEXTROSE 25 G; L-LEUCINE 182.5 MG; L-PHENYLALANINE 140 MG; L-LYSINE (L-LYSINE HYDROCHLORIDE) 145 MG; METHIONINE 100 MG; L-ISOLEUCINE 150 MG; L-VALINE 145 MG; HISTIDINE 120 MG; L-THREONINE 105 MG; TRYPTOPHAN 45 MG; L-ALANINE 520 MG; L-ARGININE 290 MG; L-PROLINE 170 MG; SERINE 125 MG; GLYCINE 260 MG; L-TYROSINE 10 MG; SODIUM ACETATE 170 MG; POTASSIUM PHOSPHATE DIBASIC 130.5 MG; SODIUM CHLORIDE 29.3 MG; MAGNESIUM CHLORIDE 25.5 MG | Cancelled Post Market | |
| 02143232 | 2.75% TRAVAS. AMINO ACID INJ.W.ELECW.25%DEX | CLINTEC NUTRITION COMPANY | Liquid | Intravenous | DEXTROSE 25 G; L-LEUCINE 201 MG; L-PHENYLALANINE 154 MG; L-LYSINE (L-LYSINE HYDROCHLORIDE) 159.5 MG; METHIONINE 110 MG; L-ISOLEUCINE 165 MG; L-VALINE 159.5 MG; HISTIDINE 132 MG; L-THREONINE 115.5 MG; TRYPTOPHAN 49.5 MG; L-ALANINE 570 MG; L-ARGININE 316 MG; L-PROLINE 187 MG; SERINE 137.5 MG; GLYCINE 283 MG; L-TYROSINE 11 MG; SODIUM ACETATE 215.5 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 112 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 02014009 | 2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE QUICKMIX | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 25 G; L-LEUCINE HYDROCHLORIDE 170 MG; L-PHENYLALANINE HYDROCHLORIDE 170 MG; L-LYSINE HYDROCHLORIDE 159 MG; METHIONINE 159 MG; L-ALANINE 570 MG; GLYCINE 570 MG; L-ARGININE 285 MG; L-ISOLEUCINE 131.5 MG; L-VALINE 126 MG; HISTIDINE 120.5 MG; L-THREONINE 115 MG; TRYPTOPHAN 49.5 MG; L-PROLINE 115 MG; L-TYROSINE 11 MG; SODIUM ACETATE 215.5 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 112 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 02013991 | 2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 5% DEXTROSE QUICKMIX | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 5 G; L-LEUCINE HYDROCHLORIDE 170 MG; L-PHENYLALANINE HYDROCHLORIDE 170 MG; L-LYSINE HYDROCHLORIDE 159 MG; METHIONINE 159 MG; L-ALANINE 570 MG; GLYCINE 570 MG; L-ARGININE 285 MG; L-ISOLEUCINE 131.5 MG; L-VALINE 126 MG; HISTIDINE 120.5 MG; L-THREONINE 115 MG; TRYPTOPHAN 49.5 MG; L-PROLINE 115 MG; L-TYROSINE 11 MG; SODIUM ACETATE 256 MG; POTASSIUM PHOSPHATE DIBASIC 215.5 MG; SODIUM CHLORIDE 112 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 02143240 | 2.75%TRAVASOL AMINO ACID INJ.W.ELEC.W.5%DEX. | CLINTEC NUTRITION COMPANY | Liquid | Intravenous | DEXTROSE 5 G; L-LEUCINE 201 MG; L-PHENYLALANINE 154 MG; L-LYSINE (L-LYSINE HYDROCHLORIDE) 159.5 MG; METHIONINE 110 MG; L-ISOLEUCINE 165 MG; L-VALINE 159.5 MG; HISTIDINE 132 MG; L-THREONINE 115.5 MG; TRYPTOPHAN 49.5 MG; L-ALANINE 570 MG; L-ARGININE 316 MG; L-PROLINE 187 MG; SERINE 137.5 MG; GLYCINE 283 MG; L-TYROSINE 11 MG; SODIUM ACETATE 215 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 112 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 01924257 | 20% DEXTROSE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 200 MG | Cancelled Post Market | |
| 02015080 | 20% DEXTROSE INJECTION, USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 20 G | Cancelled Post Market | |
| 01927981 | 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 3.3 G; SODIUM CHLORIDE 300 MG | Dormant | |
| 00038881 | 3.33% DEXTROSE AND 0.3% SODIUM CHLORIDE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 33.3 MG; SODIUM CHLORIDE 3 MG | Cancelled Post Market | |
| 02014831 | 33.3% DEXTROSE INJECTION, USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 33.3 G | Cancelled Post Market | |
| 02142414 | 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 10 G; L-LEUCINE 310 MG; L-PHENYLALANINE 238 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 246.5 MG; METHIONINE 170 MG; L-ISOLEUCINE 255 MG; L-VALINE 246.5 MG; HISTIDINE 204 MG; L-THREONINE 178.5 MG; TRYPTOPHAN 76.5 MG; L-ALANINE 880 MG; L-ARGININE 489 MG; L-PROLINE 289 MG; SERINE 212.5 MG; GLYCINE 438 MG; L-TYROSINE 17 MG; SODIUM ACETATE 297 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 77 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 02142406 | 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 20 G; L-LEUCINE 310 MG; L-PHENYLALANINE 238 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 246.5 MG; METHIONINE 170 MG; L-ISOLEUCINE 255 MG; L-VALINE 246.5 MG; HISTIDINE 204 MG; L-THREONINE 178.5 MG; TRYPTOPHAN 76.5 MG; L-ALANINE 880 MG; L-ARGININE 489 MG; L-PROLINE 289 MG; SERINE 212.5 MG; GLYCINE 438 MG; L-TYROSINE 17 MG; SODIUM ACETATE 297 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 77 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 02014033 | 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE QUICKMIX | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 20 G; L-LEUCINE HYDROCHLORIDE 263 MG; L-PHENYLALANINE HYDROCHLORIDE 263 MG; L-LYSINE HYDROCHLORIDE 246 MG; METHIONINE 246 MG; L-ALANINE 880 MG; GLYCINE 880 MG; L-ARGININE 440 MG; L-ISOLEUCINE 203 MG; L-VALINE 195 MG; HISTIDINE 186 MG; L-THREONINE 178 MG; TRYPTOPHAN 76 MG; L-PROLINE 178 MG; L-TYROSINE 17 MG; SODIUM ACETATE 297 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 77 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 02142392 | 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 25 G; L-LEUCINE 310 MG; L-PHENYLALANINE 238 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 246.5 MG; METHIONINE 170 MG; L-ISOLEUCINE 255 MG; L-VALINE 246.5 MG; HISTIDINE 204 MG; L-THREONINE 178.5 MG; TRYPTOPHAN 76.5 MG; L-ALANINE 880 MG; L-ARGININE 489 MG; L-PROLINE 289 MG; SERINE 212.5 MG; GLYCINE 438 MG; L-TYROSINE 17 MG; SODIUM ACETATE 297 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 77 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 02014017 | 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 5% DEXTROSE QUICKMIX | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 5 G; L-LEUCINE HYDROCHLORIDE 263 MG; L-PHENYLALANINE HYDROCHLORIDE 263 MG; L-LYSINE HYDROCHLORIDE 246 MG; METHIONINE 246 MG; L-ALANINE 880 MG; GLYCINE 880 MG; L-ARGININE 440 MG; L-ISOLEUCINE 203 MG; L-VALINE 195 MG; HISTIDINE 186 MG; L-THREONINE 178 MG; TRYPTOPHAN 76 MG; L-PROLINE 178 MG; L-TYROSINE 17 MG; SODIUM ACETATE 297 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 77 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 02142317 | 4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTRLYTES IN 10% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 10 G; L-LEUCINE 310 MG; L-PHENYLALANINE 238 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 246.5 MG; METHIONINE 170 MG; L-ISOLEUCINE 255 MG; L-VALINE 246.5 MG; HISTIDINE 204 MG; L-THREONINE 178.5 MG; TRYPTOPHAN 76.5 MG; L-ALANINE 880 MG; L-ARGININE 489 MG; L-PROLINE 289 MG; SERINE 212.5 MG; GLYCINE 438 MG; L-TYROSINE 17 MG | Cancelled Post Market | |
| 02142309 | 4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 20 G; L-LEUCINE 310 MG; L-PHENYLALANINE 238 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 246.5 MG; METHIONINE 170 MG; L-ISOLEUCINE 255 MG; L-VALINE 246.5 MG; HISTIDINE 204 MG; L-THREONINE 178.5 MG; TRYPTOPHAN 76.5 MG; L-ALANINE 880 MG; L-ARGININE 489 MG; L-PROLINE 289 MG; SERINE 212.5 MG; GLYCINE 438 MG; L-TYROSINE 17 MG | Cancelled Post Market | |
| 02142295 | 4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 25% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 25 G; L-LEUCINE 310 MG; L-PHENYLALANINE 238 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 246.5 MG; METHIONINE 170 MG; L-ISOLEUCINE 255 MG; L-VALINE 246.5 MG; HISTIDINE 204 MG; L-THREONINE 178.5 MG; TRYPTOPHAN 76.5 MG; L-ALANINE 880 MG; L-ARGININE 489 MG; L-PROLINE 289 MG; SERINE 212.5 MG; GLYCINE 438 MG; L-TYROSINE 17 MG | Cancelled Post Market | |
| 02013894 | 4.25% TRAVASOL AMINO ACID WITHOUT ELECTROLYTES IN 5% DEXTROSE QUICKMIX | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 5 G; L-LEUCINE HYDROCHLORIDE 263 MG; L-PHENYLALANINE HYDROCHLORIDE 263 MG; L-LYSINE HYDROCHLORIDE 246 MG; METHIONINE 246 MG; L-ALANINE 880 MG; GLYCINE 880 MG; L-ARGININE 440 MG; L-ISOLEUCINE 203 MG; L-VALINE 195 MG; HISTIDINE 186 MG; L-THREONINE 178 MG; TRYPTOPHAN 76 MG; L-PROLINE 178 MG; L-TYROSINE 17 MG | Cancelled Post Market | |
| 02142325 | 4.25%TRAV. AMINO ACID INJ.W.O.ELECT.5%DEXT. | CLINTEC NUTRITION COMPANY | Liquid | Intravenous | DEXTROSE 5 G; L-LEUCINE 310 MG; L-PHENYLALANINE 238 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 246.5 MG; METHIONINE 170 MG; L-ISOLEUCINE 255 MG; L-VALINE 246.5 MG; HISTIDINE 204 MG; L-THREONINE 178.5 MG; TRYPTOPHAN 76.5 MG; L-ALANINE 880 MG; L-ARGININE 489 MG; L-PROLINE 289 MG; SERINE 212.5 MG; GLYCINE 438 MG; L-TYROSINE 17 MG | Cancelled Post Market | |
| 01947230 | 40% DEXTROSE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 40 % | Cancelled Post Market | |
| 02014858 | 40% DEXTROSE INJECTION, USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 40 G | Cancelled Post Market | |
| 01927558 | 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 200 MG | Dormant | |
| 00038873 | 5% DEXTROSE AND 0.225% SODIUM CHLORIDE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 50 MG; SODIUM CHLORIDE 2.25 MG | Cancelled Post Market | |
| 00038903 | 5% DEXTROSE AND 0.45% SODIUM CHLORIDE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 50 MG; SODIUM CHLORIDE 4.5 MG | Dormant | |
| 00038946 | 5% DEXTROSE AND 0.9% SODIUM CHLORIDE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 50 MG; SODIUM CHLORIDE 9 MG | Dormant | |
| 01931652 | 5% DEXTROSE IN LACTATED RINGER'S INJECTION | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 600 MG; SODIUM LACTATE 310 MG; POTASSIUM CHLORIDE 30 MG; CALCIUM CHLORIDE 20 MG | Cancelled Post Market | |
| 02142368 | 5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 20 G; L-LEUCINE 365 MG; L-PHENYLALANINE 280 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 290 MG; METHIONINE 200 MG; L-ISOLEUCINE 300 MG; L-VALINE 290 MG; HISTIDINE 240 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-ALANINE 1.04 G; L-ARGININE 575 MG; L-PROLINE 340 MG; SERINE 250 MG; GLYCINE 515 MG; L-TYROSINE 20 MG; SODIUM ACETATE 340 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 58.5 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 02142252 | 5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 20 G; L-LEUCINE 365 MG; L-PHENYLALANINE 280 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 290 MG; METHIONINE 200 MG; L-ISOLEUCINE 300 MG; L-VALINE 290 MG; HISTIDINE 240 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-ALANINE 1.04 G; L-ARGININE 575 MG; L-PROLINE 340 MG; SERINE 250 MG; GLYCINE 515 MG; L-TYROSINE 20 MG | Cancelled Post Market | |
| 02142244 | 5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 25% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 25 G; L-LEUCINE 365 MG; L-PHENYLALANINE 280 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 290 MG; METHIONINE 200 MG; L-ISOLEUCINE 300 MG; L-VALINE 290 MG; HISTIDINE 240 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-ALANINE 1.04 G; L-ARGININE 575 MG; L-PROLINE 340 MG; SERINE 250 MG; GLYCINE 515 MG; L-TYROSINE 20 MG | Cancelled Post Market | |
| 01924273 | 50% DEXTROSE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 500 MG | Cancelled Post Market | |
| 02014866 | 50% DEXTROSE INJECTION, USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 50 G | Cancelled Post Market | |
| 02003651 | 50GM GLUCOSE TOLERANCE DRINK | CRITERION SCIENCES | Liquid | Oral | DEXTROSE 5 G | Cancelled Post Market | |
| 01924265 | 70% DEXTROSE INJECTION USP | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 70 G | Cancelled Pre Market | |
| 02003643 | 75GM GLUCOSE TOLERANCE DRINK | CRITERION SCIENCES | Liquid | Oral | DEXTROSE 7.5 G | Cancelled Post Market | |
| 00108081 | A-C-D SOLUTION | DRAXIMAGE A DIVISION OF DRAXIS SPECIALTY PHARMACEUTICALS INC | Liquid | Intravenous | DEXTROSE 132 MG; SODIUM CITRATE 250 MG; CITRIC ACID 80 MG | Cancelled Post Market | |
| 00770213 | ACID CONCENTRATE 2125 | BAXTER CORPORATION | Solution | Haemodialysis | DEXTROSE 89.99 G; SODIUM CHLORIDE 268.24 G; POTASSIUM CHLORIDE 3.35 G; CALCIUM CHLORIDE 7.74 G; MAGNESIUM CHLORIDE 3.21 G; ACETIC ACID 8.11 G | Cancelled Post Market | |
| 02324393 | ADDITIVE SOLUTION FORMULA 3 AS-3 | TERUMO BCT, INC. | Solution | Extracorporeal | DEXTROSE 1.10 G; SODIUM CITRATE DIHYDRATE 0.588 G; SODIUM CHLORIDE 0.410 G; SODIUM PHOSPHATE MONOBASIC, MONOHYDRATE 0.276 G; CITRIC ACID MONOHYDRATE 0.042 G; ADENINE 0.030 G | Dormant | |
| 00508365 | AMINO ACID FORMULA INJ | CENTRAL SALES LIMITED | Liquid | Intravenous | DEXTROSE 50 G; CALCIUM CHLORIDE 150 MG; POTASSIUM CHLORIDE 200 MG; MAGNESIUM SULFATE 200 MG; SODIUM ACETATE 2.5 G; SODIUM GLUTAMATE 40 MG; RIBOFLAVIN-5-PHOSPHATE 40 MG; CALCIUM D-PANTOTHENATE 50 MG; VITAMIN B12 50 MCG; PYRIDOXINE HYDROCHLORIDE 100 MG; NICOTINAMIDE 1.5 G; THIAMINE HYDROCHLORIDE 100 MG; L-ASPARTIC ACID 24.7 MG; THREONINE 14.4 MG; SERINE 18.9 MG; GLUTAMIC ACID 66.6 MG; PROLINE 33.6 MG; GLYCINE 6.7 MG; ALANINE 10.5 MG; VALINE 22.3 MG; METHIONINE 9.1 MG; ISOLEUCINE 17.5 MG; LEUCINE 28.5 MG; TYROSINE 4.9 MG; PHENYLALANINE 15.2 MG; HISTIDINE 8.9 MG; LYSINE 25.8 MG; ARGININE 11.8 MG; TRYPTOPHAN 3.8 MG | Cancelled Post Market | |
| 00154032 | AMINO ACID INJ | ORMOND VETERINARY SUPPLY LTD. | Liquid | Intravenous; Intraperitoneal; Subcutaneous; Intramuscular | DEXTROSE 5 G; SODIUM ACETATE 250 MG; CALCIUM CHLORIDE 15 MG; POTASSIUM CHLORIDE 20 MG; MAGNESIUM SULFATE 20 MG; ARGININE 2 MG; HISTIDINE 1.4 MG; LEUCINE 4 MG; ISOLEUCINE 2 MG; LYSINE 4 MG; PHENYLALANINE 3 MG; METHIONINE 1 MG; THREONINE 2 MG; TRYPTOPHAN 1 MG; VALINE 3 MG; L-CYSTEINE HYDROCHLORIDE 1 MG; VITAMIN B1 10 MG; VITAMIN B2 4 MG; NICOTINAMIDE 150 MG; D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 5 MG; PYRIDOXINE HYDROCHLORIDE 10 MG; VITAMIN B12 5 MCG | Cancelled Post Market | |
| 00626368 | AMINO ACID INJECTABLE | UNIVET PHARMACEUTICALS LTD. | Solution | Intraperitoneal; Subcutaneous; Intravenous | DEXTROSE 5 G; SODIUM ACETATE 250 MG; CALCIUM CHLORIDE 15 MG; POTASSIUM CHLORIDE 20 MG; MAGNESIUM SULFATE 20 MG; THIAMINE HYDROCHLORIDE 10 MG; VITAMIN B2 4 MG; DEXPANTHENOL 5 MG; NICOTINAMIDE 150 MG; PYRIDOXINE HYDROCHLORIDE 10 MG; VITAMIN B12 5 MCG; SODIUM GLUTAMATE 4 MG; CASEIN HYDROLYSATE 71.3 MG; L-ASPARTIC ACID 4.7 MG; THREONINE 2.7 MG; SERINE 3.6 MG; GLUTAMIC ACID 12.8 MG; PROLINE 6.4 MG; GLYCINE 1.2 MG; ALANINE 2 MG; VALINE 4.2 MG; DL-METHIONINE 1.7 MG; ISOLEUCINE 3.3 MG; LEUCINE 5.4 MG; TYROSINE .9 MG; PHENYLALANINE 2.9 MG; HISTIDINE 1.7 MG; LYSINE 4.9 MG; ARGININE 2.2 MG; TRYPTOPHAN .7 MG | Cancelled Post Market | |
| 02000806 | AMINO ACID LIQ | MEDPRODEX INC. | Liquid | Oral | DEXTROSE 50 MG; SODIUM ACETATE 2.5 MG; CALCIUM CHLORIDE 0.15 MG; POTASSIUM CHLORIDE 0.2 MG; MAGNESIUM SULFATE 0.2 MG; ARGININE HYDROCHLORIDE 0.025 MG; SODIUM GLUTAMATE 0.04 MG; HISTIDINE MONOHYDROCHLORIDE 0.01 MG; L-LEUCINE 0.04 MG; DL-ISOLEUCINE 0.02 MG; L-LYSINE HYDROCHLORIDE 0.03 MG; METHIONINE 0.01 MG; PHENYLALANINE 0.03 MG; L-THREONINE 0.02 MG; DL-TRYPTOPHANE 0.01 MG; DL-VALINE 0.05 MG; L-CYSTEINE HYDROCHLORIDE 0.01 MG; THIAMINE HYDROCHLORIDE 0.1 MG; VITAMIN B2 0.04 MG; NICOTINAMIDE 1.5 MG; DEXPANTHENOL 0.05 MG; PYRIDOXINE HYDROCHLORIDE 0.1 MG; VITAMIN B12 0.05 MCG | Cancelled Post Market | |
| 00609919 | AMINO LITE | ANCHOR, DIVISION OF BOEHRINGER INGELHEIM | Liquid | Intraperitoneal; Intravenous | DEXTROSE 5 G; CALCIUM CHLORIDE 15 MG; POTASSIUM CHLORIDE 20 MG; MAGNESIUM SULFATE 20 MG; HISTIDINE MONOHYDROCHLORIDE 1 MG; METHIONINE 1 MG; TRYPTOPHAN 1 MG; L-CYSTEINE HYDROCHLORIDE 1 MG; THREONINE 2 MG; ISOLEUCINE 2 MG; ARGININE 2.5 MG; PHENYLALANINE 3 MG; VALINE 5 MG; L-LYSINE HYDROCHLORIDE 3 MG; LEUCINE 4 MG; SODIUM GLUTAMATE 4 MG; VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM) 4 MG; VITAMIN B12 5 MCG; PYRIDOXINE HYDROCHLORIDE 10 MG; NICOTINIC ACID 150 MG; THIAMINE HYDROCHLORIDE 10 MG | Cancelled Post Market | |
| 00319341 | AMINO SOLUTION | PROFESSIONAL VETERINARY LABORATORIES | Solution | Intravenous | DEXTROSE 5 G; SODIUM ACETATE 250 MG; CALCIUM CHLORIDE 15 MG; POTASSIUM CHLORIDE 20 MG; MAGNESIUM SULFATE 20 MG; VITAMIN B1 10 MG; VITAMIN B2 4 MG; NICOTINAMIDE 150 MG; CALCIUM D-PANTOTHENATE 5 MG; VITAMIN B6 10 MG; VITAMIN B12 5 MCG; POTASSIUM 2.7 mEq; SODIUM 30 mEq; VALINE 3 MG; LEUCINE 4 MG; ISOLEUCINE 2 MG; THREONINE 2 MG; LYSINE 4 MG; TRYPTOPHAN 1 MG; PHENYLALANINE 3 MG; HISTIDINE 1.4 MG; DL-METHIONINE 1 MG; ARGININE 2 MG; CASEIN HYDROLYSATE NIL | Dormant | |
| 02283514 | AMINO-JUG | WYETH ANIMAL HEALTH, DIVISION OF WYETH CANADA | Solution | Intraperitoneal; Intravenous | DEXTROSE 5 G; CALCIUM CHLORIDE 15 MG; POTASSIUM CHLORIDE 20 MG; MAGNESIUM SULFATE 20 MG; SODIUM ACETATE 250 MG; DEXPANTHENOL (CALCIUM D-PANTOTHENATE) 5 MG; THIAMINE HYDROCHLORIDE 10 MG; NICOTINAMIDE 150 MG; PYRIDOXINE HYDROCHLORIDE 10 MG; RIBOFLAVIN 5'-PHOSPHATE SODIUM 4 MG; VITAMIN B12 5 MCG; HISTIDINE 0.9 MG; DL-METHIONINE 0.3 MG; TRYPTOPHAN 0.3 MG; ISOLEUCINE 1.6 MG; ARGININE 1 MG; PHENYLALANINE 1 MG; VALINE 2 MG; LYSINE 2.5 MG; LEUCINE 2.5 MG; THREONINE 1.4 MG; L-ASPARTIC ACID 2 MG; SERINE 1.6 MG; GLUTAMIC ACID 6.7 MG; PROLINE 3.3 MG; GLYCINE 0.6 MG; ALANINE 0.8 MG; TYROSINE 0.2 MG | Cancelled Post Market | |
| 01960865 | ANTICOAGULANT CIT PHOS DEX ADENINE SOL USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 2 G; SODIUM CITRATE 1.66 G; CITRIC ACID 189 MG; SODIUM PHOSPHATE MONOBASIC 140 MG; ADENINE 17.3 MG | Cancelled Post Market | |
| 00788112 | ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA B | FENWAL INC | Solution | 0-Unassigned | DEXTROSE 1.47 G; SODIUM CITRATE 1.32 G; CITRIC ACID 440 MG | Cancelled Post Market | |
| 02137976 | B.D GLUCOSE TABLETS - 5GM | BECTON DICKINSON | Tablet | Oral | DEXTROSE 5 G | Cancelled Post Market | |
| 02011638 | CALF-LYTE II PWS | AUSTIN, DIVISION OF VÉTOQUINOL N.-A. INC. | Powder For Solution | Oral | DEXTROSE 43.208 G; SODIUM CHLORIDE 3.507 G; GLYCINE 6.756 G; POTASSIUM CHLORIDE 1.94 G; SODIUM ACETATE 9.845 G; SODIUM PHOSPHATE MONOBASIC 600 MG; POTASSIUM PHOSPHATE DIBASIC 349 MG; CALCIUM D-PANTOTHENATE 12 MG | Cancelled Post Market | |
| 00856320 | CALF-LYTE SOLUTION | VETOQUINOL N A INC | Solution | Intravenous | DEXTROSE 10.80 MG; SODIUM ACETATE 4.08 MG; SODIUM BICARBONATE 4.20 MG; SODIUM CHLORIDE 3.51 MG; POTASSIUM CHLORIDE 0.45 MG; MAGNESIUM CHLORIDE 0.20 MG | Cancelled Post Market | |
| 02142279 | CLINIMIX | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 10 G; L-LEUCINE 365 MG; L-PHENYLALANINE 280 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 290 MG; METHIONINE 200 MG; L-ISOLEUCINE 300 MG; L-VALINE 290 MG; HISTIDINE 240 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-ALANINE 1.04 G; L-ARGININE 575 MG; L-PROLINE 340 MG; SERINE 250 MG; GLYCINE 515 MG; L-TYROSINE 20 MG | Cancelled Post Market | |
| 02013916 | CLINIMIX | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 25 G; L-LEUCINE HYDROCHLORIDE 263 MG; L-PHENYLALANINE HYDROCHLORIDE 263 MG; L-LYSINE HYDROCHLORIDE 246 MG; METHIONINE 246 MG; L-ALANINE 880 MG; GLYCINE 880 MG; L-ARGININE 440 MG; L-ISOLEUCINE 203 MG; L-VALINE 195 MG; HISTIDINE 186 MG; L-THREONINE 178 MG; TRYPTOPHAN 76 MG; L-PROLINE 178 MG; L-TYROSINE 17 MG | Cancelled Post Market | |
| 02013924 | CLINIMIX | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 10 G; L-LEUCINE HYDROCHLORIDE 263 MG; L-PHENYLALANINE HYDROCHLORIDE 263 MG; L-LYSINE HYDROCHLORIDE 246 MG; METHIONINE 246 MG; L-ALANINE 880 MG; GLYCINE 880 MG; L-ARGININE 440 MG; L-ISOLEUCINE 203 MG; L-VALINE 195 MG; HISTIDINE 186 MG; L-THREONINE 178 MG; TRYPTOPHAN 76 MG; L-PROLINE 178 MG; L-TYROSINE 17 MG | Cancelled Post Market | |
| 02013959 | CLINIMIX | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 25 G; L-LEUCINE HYDROCHLORIDE 310 MG; L-PHENYLALANINE HYDROCHLORIDE 310 MG; L-LYSINE HYDROCHLORIDE 290 MG; METHIONINE 290 MG; L-ALANINE 1.04 G; GLYCINE 1.04 G; L-ARGININE 520 MG; L-ISOLEUCINE 240 MG; L-VALINE 230 MG; HISTIDINE 220 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-PROLINE 210 MG; L-TYROSINE 20 MG | Cancelled Post Market | |
| 02142260 | CLINIMIX | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 16.6 G; L-LEUCINE 365 MG; L-PHENYLALANINE 280 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 290 MG; METHIONINE 200 MG; L-ISOLEUCINE 300 MG; L-VALINE 290 MG; HISTIDINE 240 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-ALANINE 1.04 G; L-ARGININE 575 MG; L-PROLINE 340 MG; SERINE 250 MG; GLYCINE 515 MG; L-TYROSINE 20 MG | Cancelled Post Market | |
| 02142333 | CLINIMIX 2.5% TRAVASOL AA WITHOUT ELECTROLYTES IN 10% DEXTROSE INJEC | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | Solution | Intravenous | DEXTROSE 10 G; L-LEUCINE 182.5 MG; L-PHENYLALANINE 140 MG; L-LYSINE (L-LYSINE HYDROCHLORIDE) 145 MG; METHIONINE 100 MG; L-ISOLEUCINE 150 MG; L-VALINE 145 MG; HISTIDINE 120 MG; L-THREONINE 105 MG; TRYPTOPHAN 45 MG; L-ALANINE 520 MG; L-ARGININE 290 MG; L-PROLINE 170 MG; SERINE 125 MG; GLYCINE 260 MG; L-TYROSINE 10 MG | Cancelled Post Market | |
| 02142341 | CLINIMIX E | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 25 G; L-LEUCINE 365 MG; L-PHENYLALANINE 280 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 290 MG; METHIONINE 200 MG; L-ISOLEUCINE 300 MG; L-VALINE 290 MG; HISTIDINE 240 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-ALANINE 1.04 G; L-ARGININE 575 MG; L-PROLINE 340 MG; SERINE 250 MG; GLYCINE 515 MG; L-TYROSINE 20 MG; SODIUM ACETATE 340 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 58.5 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 02142376 | CLINIMIX E | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 16.6 G; L-LEUCINE 365 MG; L-PHENYLALANINE 280 MG; LYSINE (L-LYSINE HYDROCHLORIDE) 290 MG; METHIONINE 200 MG; L-ISOLEUCINE 300 MG; L-VALINE 290 MG; HISTIDINE 240 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-ALANINE 1.04 G; L-ARGININE 575 MG; L-PROLINE 340 MG; SERINE 250 MG; GLYCINE 515 MG; L-TYROSINE 20 MG; SODIUM ACETATE 205 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 58.5 MG; MAGNESIUM CHLORIDE 24 MG | Cancelled Post Market | |
| 02014025 | CLINIMIX E | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 10 G; L-LEUCINE HYDROCHLORIDE 263 MG; L-PHENYLALANINE HYDROCHLORIDE 263 MG; L-LYSINE HYDROCHLORIDE 246 MG; METHIONINE 246 MG; L-ALANINE 880 MG; GLYCINE 880 MG; L-ARGININE 440 MG; L-ISOLEUCINE 203 MG; L-VALINE 195 MG; HISTIDINE 186 MG; L-THREONINE 178 MG; TRYPTOPHAN 76 MG; L-PROLINE 178 MG; L-TYROSINE 17 MG; SODIUM ACETATE 297 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 77 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 02014041 | CLINIMIX E | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 25 G; L-LEUCINE HYDROCHLORIDE 263 MG; L-PHENYLALANINE HYDROCHLORIDE 263 MG; L-LYSINE HYDROCHLORIDE 246 MG; METHIONINE 246 MG; L-ALANINE 880 MG; GLYCINE 880 MG; L-ARGININE 440 MG; L-ISOLEUCINE 203 MG; L-VALINE 195 MG; HISTIDINE 186 MG; L-THREONINE 178 MG; TRYPTOPHAN 76 MG; L-PROLINE 178 MG; L-TYROSINE 17 MG; SODIUM ACETATE 297 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 77 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 02014084 | CLINIMIX E | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 25 G; L-LEUCINE HYDROCHLORIDE 310 MG; L-PHENYLALANINE HYDROCHLORIDE 310 MG; L-LYSINE HYDROCHLORIDE 290 MG; METHIONINE 290 MG; L-ALANINE 1.04 G; GLYCINE 1.04 G; L-ARGININE 520 MG; L-ISOLEUCINE 240 MG; L-VALINE 230 MG; HISTIDINE 220 MG; L-THREONINE 210 MG; TRYPTOPHAN 90 MG; L-PROLINE 210 MG; L-TYROSINE 20 MG; SODIUM ACETATE 340 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; SODIUM CHLORIDE 58.5 MG; MAGNESIUM CHLORIDE 51 MG | Cancelled Post Market | |
| 00516775 | CPD ADENINE CPDA 1 | FENWAL LABS, DIVISION OF BAXTER CORPORATION | Liquid | Intravenous | DEXTROSE 3.17 G; SODIUM CITRATE 2.63 G; CITRIC ACID 330 MG; SODIUM PHOSPHATE MONOBASIC 220 MG; ADENINE 28 MG | Cancelled Post Market | |
| 02228661 | D-LITE - PWR ORL | DISPAR, DIVISION OF VÉTOQUINOL N.-A. INC. | Powder | Oral | DEXTROSE 43.208 G; SODIUM CHLORIDE 3.507 G; GLYCINE 6.756 G; POTASSIUM CHLORIDE 1.94 G; SODIUM ACETATE 9.845 G; SODIUM PHOSPHATE MONOBASIC 600 MG; POTASSIUM PHOSPHATE DIBASIC 349 MG; CALCIUM D-PANTOTHENATE 12 MG | Cancelled Post Market | |
| 02025515 | DELFLEX A PERIT.DIAL.SOLN W.4.25%DEXT.LOW MG | FRESENIUS USA MANUFACTURING INC | Solution | Intraperitoneal | DEXTROSE 4.25 G; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 5.08 MG | Cancelled Post Market | |
| 02025469 | DELFLEX A PERIT.DIAL.SOLN.W.1.5%DEXT.LOW MG | FRESENIUS USA MANUFACTURING INC | Solution | Intraperitoneal | DEXTROSE 1.5 G; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 5.08 MG | Cancelled Post Market | |
| 02025493 | DELFLEX A PERIT.DIAL.SOLN.W.2.5%DEXT.LOW MG | FRESENIUS USA MANUFACTURING INC | Solution | Intraperitoneal | DEXTROSE 2.5 G; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 5.08 MG | Cancelled Post Market | |
| 02025485 | DELFLEX A PERITON.DIAL.SOLN. W.2.5% DEXTROSE | FRESENIUS USA MANUFACTURING INC | Solution | Intraperitoneal | DEXTROSE 2.5 G; SODIUM CHLORIDE 567 MG; SODIUM LACTATE 392 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 15.2 MG | Cancelled Post Market | |
| 02025477 | DELFLEX A PERITON.DIAL.SOLN.W.1.5% DEXTROSE | FRESENIUS USA MANUFACTURING INC | Solution | Intraperitoneal | DEXTROSE 1.5 G; SODIUM CHLORIDE 567 MG; SODIUM LACTATE 392 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 15.2 MG | Cancelled Post Market | |
| 02025531 | DELFLEX PERIT.DIAL.SOL.1.5%DEX.LOW CA LOW MG | FRESENIUS USA MANUFACTURING INC | Solution | Intraperitoneal | DEXTROSE 1.5 G; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 18.4 MG; MAGNESIUM CHLORIDE 5.08 MG | Cancelled Post Market | |
| 02025523 | DELFLEX PERIT.DIAL.SOL.2.5%DEX.LOW CA LOW MG | FRESENIUS USA MANUFACTURING INC | Solution | Intraperitoneal | DEXTROSE 2.5 G; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 18.4 MG; MAGNESIUM CHLORIDE 5.08 MG | Cancelled Post Market | |
| 02025930 | DELFLEX PERIT.DIAL.SOL.4.25%DEX.LOW CALOW MG | FRESENIUS USA MANUFACTURING INC | Solution | Intraperitoneal | DEXTROSE 4.25 G; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 18.4 MG; MAGNESIUM CHLORIDE 5.08 MG | Cancelled Post Market | |
| 02242311 | DELFLEX PERITONEAL DIALYSIS SOLUTION WITH 0.5% DEXTROSE | FRESENIUS MEDICAL CARE CANADA INC | Liquid | Haemodialysis | DEXTROSE 500 MG; SODIUM LACTATE 392 MG; SODIUM CHLORIDE 562 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 15.2 MG | Cancelled Post Market | |
| 02290723 | DEX 50 | RAFTER 8 PRODUCTS INC | Solution | Intravenous; Intraperitoneal | DEXTROSE 50 % | Cancelled Post Market | |
| 00623563 | DEXTROJECT 25% | OMEGA LABORATORIES LIMITED | Solution | Intravenous | DEXTROSE 250 MG | Cancelled Post Market | |
| 00060720 | DEXTROSE 2.5% AND SOD CHLORIDE 0.45% INJ USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 2.5 G; SODIUM CHLORIDE 450 MG | Cancelled Post Market | |
| 01931660 | DEXTROSE 2.5% IN HALF STRENGTH LACTATED RINGER'S INJECTION, USP | B. BRAUN MEDICAL INC | Liquid | Intravenous | DEXTROSE 2.5 G; SODIUM CHLORIDE 300 MG; SODIUM LACTATE 160 MG; POTASSIUM CHLORIDE 15 MG; CALCIUM CHLORIDE 10 MG | Cancelled Post Market | |
| 00579440 | DEXTROSE 33.3% IN WATER INJ | ABBOTT LABORATORIES, LIMITED | Solution | Intravenous | DEXTROSE 333 MG | Cancelled Post Market | |
| 00261335 | DEXTROSE 5% AND ELECTROLYTE NO75 INJ | BAXTER CORPORATION | Liquid | Intravenous | DEXTROSE 5 G; SODIUM LACTATE 220 MG; POTASSIUM CHLORIDE 205 MG; SODIUM CHLORIDE 120 MG; POTASSIUM PHOSPHATE MONOBASIC 100 MG | Cancelled Post Market | |
| 00786179 | DEXTROSE 5% AND SOD CHLORIDE 0.33% INJ USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 330 MG | Cancelled Post Market | |
| 00306401 | DEXTROSE 50% | DISPAR, DIVISION OF VÉTOQUINOL N.-A. INC. | Solution | Intraperitoneal; Intramuscular; Intravenous; Subcutaneous | DEXTROSE 50 % | Cancelled Post Market | |
| 02350521 | DEXTROSE 50% | VALESCO PHARMACEUTICALS INC | Solution | Intraperitoneal; Intravenous | DEXTROSE 50 % | Cancelled Post Market | |
| 00600148 | DEXTROSE 50% INJ | CDMV INC. | Liquid | Intraperitoneal; Intravenous | DEXTROSE 500 MG | Cancelled Post Market | |
| 00494704 | DEXTROSE 50% INJ W ELECTROLYTES PF ABBOVAC | HOSPIRA HEALTHCARE ULC | Solution | Intravenous | DEXTROSE 50 G; POTASSIUM PHOSPHATE DIBASIC 418 MG; POTASSIUM CHLORIDE 239 MG; MAGNESIUM CHLORIDE 169.6 MG; SODIUM ACETATE 295 MG; SODIUM CHLORIDE 374 MG | Cancelled Post Market | |
| 00051861 | DEXTROSE 50% INJECTABLE STERILE SOLUTION | VETOQUINOL N A INC | Solution | Intraperitoneal; Intravenous | DEXTROSE 500 MG | Cancelled Post Market | |
| 00611263 | DEXTROSE 50% SOLN | UNIVET PHARMACEUTICALS LTD. | Solution | Intravenous; Intraperitoneal | DEXTROSE 50 % | Cancelled Post Market | |
| 00308374 | DEXTROSE CALCIUM GLUCONATE MAGNESIUM PHOS | PROFESSIONAL VETERINARY LABORATORIES | Liquid | Intravenous | DEXTROSE 75 G; CALCIUM GLUCONATE 100 G; MAGNESIUM HYPOPHOSPHITE 3 G | Dormant | |
| 00613452 | DEXTROSE INJ 13.3% | ABBOTT LABORATORIES, LIMITED | Liquid | Intravenous | DEXTROSE 13.3 G | Cancelled Post Market | |
| 00243558 | DEXTROSE INJ 25% | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | Intravenous | DEXTROSE 250 MG | Cancelled Post Market | |
| 00598046 | DEXTROSE INJ 5% | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | Intravenous | DEXTROSE 50 MG | Cancelled Post Market | |
| 00243566 | DEXTROSE INJ 50% | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | Intravenous | DEXTROSE 500 MG | Cancelled Post Market | |
| 00703699 | DEXTROSE INJ 500MG/ML USP | ASTRA PHARMA INC. | Liquid | Intravenous | DEXTROSE 500 MG | Cancelled Post Market | |
| 00824941 | DEXTROSE INJ LIQ 50% | BIONICHE PHARMA (CANADA) LTD | Liquid | Intravenous | DEXTROSE 50 % | Cancelled Post Market | |
| 00037958 | DEXTROSE INJECTION USP | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 100 MG | Dormant | |
| 00037974 | DEXTROSE INJECTION USP | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 500 MG | Dormant | |
| 00244988 | DEXTROSE INJECTION USP | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 700 MG | Dormant | |
| 00037966 | DEXTROSE INJECTION USP | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 200 MG | Dormant | |
| 00470953 | DEXTROSE INJECTION USP | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 400 MG | Cancelled Post Market | |
| 00315850 | DEXTROSE LIQ 50% | ARMITAGE CARROLL, DIVISION OF LANGFORD INC. | Liquid | Intraperitoneal; Intramuscular; Subcutaneous; Intravenous | DEXTROSE 50 G | Cancelled Post Market | |
| 01939777 | DEXTROSE LIQ 50% | CITADEL ANIMAL HEALTH | Solution | Intraperitoneal; Intravenous | DEXTROSE 50 % | Cancelled Post Market | |
| 00308366 | DEXTROSE PLUS ELECTROLYTES | PROFESSIONAL VETERINARY LABORATORIES | Solution | Intraperitoneal; Intravenous; Intramuscular | DEXTROSE 250 G; SODIUM CHLORIDE 4.59 G; MAGNESIUM CHLORIDE 270 MG; CALCIUM CHLORIDE 490 MG; SODIUM ACETATE 4.68 G; POTASSIUM ACETATE 900 MG; SODIUM BISULFITE 1.8 G | Dormant | |
| 00798908 | DEXTROSE-35 5.55 - 4.5 | BAXTER CORPORATION | Powder For Solution | Haemodialysis | DEXTROSE 173.2 G | Cancelled Post Market | |
| 00890162 | DEXTROSE-35 6.66 - 4.5 | ALTHIN BIOPHARM INC. | Powder For Solution | Haemodialysis | DEXTROSE 207.9 G | Cancelled Post Market | |
| 02161044 | DEXTROSE-36.8 5.55-4.5 | BAXTER CORPORATION | Powder | Haemodialysis | DEXTROSE 182.1 G | Cancelled Post Market | |
| 02160978 | DEXTROSE-45 5.55-4.5 | BAXTER CORPORATION | Powder | Haemodialysis | DEXTROSE 222.7 G | Cancelled Post Market | |
| 00799831 | DIANEAL PD 102 CAPD SOLUTION W 1.5% DEXTROSE | BAXTER CORPORATION | Liquid | Haemodialysis | DEXTROSE 1.5 G; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 15.2 MG | Cancelled Post Market | |
| 00799858 | DIANEAL PD 102 CAPD SOLUTION W 4.25% DEXTROSE | BAXTER CORPORATION | Liquid | Haemodialysis | DEXTROSE 4.25 G; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 15.2 MG | Cancelled Post Market | |
| 00799890 | DIANEAL PD 104 CAPD SOLUTION W 0.5% DEXTROSE | BAXTER CORPORATION | Liquid | Haemodialysis | DEXTROSE 500 MG; SODIUM CHLORIDE 589 MG; SODIUM LACTATE 387 MG; CALCIUM CHLORIDE 26 MG; MAGNESIUM CHLORIDE 15 MG | Cancelled Post Market | |
| 02141558 | ELECTROLYTE-F-CALF | CAN-VET ANIMAL HEALTH SUPPLIES LTD. | Powder For Solution | Oral | DEXTROSE 43.208 G; SODIUM CHLORIDE 3.507 G; GLYCINE 6.756 G; POTASSIUM CHLORIDE 1.94 G; SODIUM ACETATE 9.845 G; SODIUM PHOSPHATE DIBASIC 0.600 G; POTASSIUM PHOSPHATE DIBASIC 0.349 G; CALCIUM D-PANTOTHENATE 0.012 G | Cancelled Post Market | |
| 02276925 | ELECTROYLTE-F-CALF HE | CAN-VET ANIMAL HEALTH SUPPLIES LTD. | Powder For Solution | Oral | DEXTROSE 152.00 G; SODIUM ACETATE 13.125 G; GLYCINE 6.006 G; SODIUM CHLORIDE 4.675 G; POTASSIUM PHOSPHATE DIBASIC 1.742 G; POTASSIUM CHLORIDE 1.491 G; CITRIC ACID 1.000 G | Cancelled Post Market | |
| 00617806 | GLUCOTOL LIQ 100GM/300ML COLA 100 | ATLAS LABS CO LTD. | Liquid | Oral | DEXTROSE 100 G | Cancelled Post Market | |
| 00617814 | GLUCOTOL LIQ 75GM/300ML COLA 75 | ATLAS LABS CO LTD. | Liquid | Oral | DEXTROSE 75 G | Cancelled Post Market | |
| 02247564 | HAEMOSOL H-602 | HAEMOTEC, A DIVISION OF FRESENIUS MEDICAL CARE CANADA INC. | Solution | Haemodialysis | DEXTROSE 98.99 G; SODIUM CHLORIDE 263.0 G; POTASSIUM CHLORIDE 10.06 G; CALCIUM CHLORIDE 9.92 G; MAGNESIUM CHLORIDE 3.43 G; ACETIC ACID 10.81 G | Cancelled Post Market | |
| 00564702 | HYDRA | VETREPHARM CANADA INC. | Powder | Oral | DEXTROSE 22.65 G; GLYCINE 9.44 G; SODIUM CITRATE 8.22 G; SODIUM CHLORIDE 7.35 G; POTASSIUM CHLORIDE 2.35 G | Cancelled Post Market | |
| 00634115 | INPERSOL LM W 1.5% DEXTROSE | ABBOTT LABORATORIES, LIMITED | Liquid | Intraperitoneal | DEXTROSE 1.5 G; SODIUM LACTATE 448 MG; SODIUM CHLORIDE 538 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 5.08 MG | Cancelled Post Market | |
| 00634131 | INPERSOL LM W 2.5% DEXTROSE | ABBOTT LABORATORIES, LIMITED | Liquid | Intraperitoneal | DEXTROSE 2.5 G; SODIUM LACTATE 448 MG; SODIUM CHLORIDE 538 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 5.08 MG | Cancelled Post Market | |
| 00634123 | INPERSOL LM W 4.25% DEXTROSE | ABBOTT LABORATORIES, LIMITED | Liquid | Intraperitoneal | DEXTROSE 4.25 G; SODIUM LACTATE 448 MG; SODIUM CHLORIDE 538 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 5.08 MG | Cancelled Post Market | |
| 00039608 | INPERSOL W DEXTROSE 1.5% | ABBOTT LABORATORIES, LIMITED | Solution | Intraperitoneal; Haemodialysis | DEXTROSE 15 MG; SODIUM LACTATE 5 MG; SODIUM CHLORIDE 5.6 MG; CALCIUM CHLORIDE .26 MG; MAGNESIUM CHLORIDE .15 MG | Cancelled Post Market | |
| 00530182 | INPERSOL W DEXTROSE 2.5% | ABBOTT LABORATORIES, LIMITED | Solution | Intraperitoneal | DEXTROSE 25 MG; SODIUM LACTATE 3.92 MG; SODIUM CHLORIDE 5.62 MG; CALCIUM CHLORIDE 0.26 MG; MAGNESIUM CHLORIDE 0.15 MG | Cancelled Post Market | |
| 00678430 | INPERSOL WITH DEXTROSE 0.5% | ABBOTT LABORATORIES, LIMITED | Liquid | Haemodialysis | DEXTROSE 500 MG; SODIUM LACTATE 392 MG; SODIUM CHLORIDE 562 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 15.2 MG | Cancelled Post Market | |
| 01931768 | ISOLYTE H WITH DEXTROSE 5% INJ | B. BRAUN MEDICAL INC | Liquid | Intravenous | DEXTROSE 5 G; SODIUM ACETATE 220 MG; SODIUM CHLORIDE 140 MG; POTASSIUM CHLORIDE 97 MG; MAGNESIUM CHLORIDE 30 MG | Cancelled Post Market | |
| 01931776 | ISOLYTE M IN 5% DEXTROSE | B. BRAUN MEDICAL INC | Liquid | Intravenous | DEXTROSE 5 G; SODIUM ACETATE 280 MG; POTASSIUM CHLORIDE 150 MG; POTASSIUM PHOSPHATE DIBASIC 130 MG; SODIUM CHLORIDE 91 MG | Cancelled Post Market | |
| 01931709 | ISOLYTE R IN 5% DEXTROSE | B. BRAUN MEDICAL INC | Liquid | Intravenous | DEXTROSE 5 G; SODIUM ACETATE 330 MG; POTASSIUM CHLORIDE 120 MG; SODIUM CHLORIDE 88 MG; CALCIUM CHLORIDE 37 MG; MAGNESIUM CHLORIDE 31 MG | Cancelled Post Market | |
| 01935992 | ISOLYTE S WITH 5% DEXTROSE INJ | B. BRAUN MEDICAL INC | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 530 MG; SODIUM GLUCONATE 500 MG; SODIUM ACETATE 370 MG; POTASSIUM CHLORIDE 37 MG; MAGNESIUM CHLORIDE 30 MG | Cancelled Post Market | |
| 00896934 | K2 WITH GLUCOSE LIQ R04977 | BDH INC. | Liquid | Haemodialysis | DEXTROSE 81.03 G; SODIUM CHLORIDE 172.2 G; POTASSIUM CHLORIDE 5.491 G; CALCIUM CHLORIDE 8.122 G; MAGNESIUM CHLORIDE 3.744 G; ACETIC ACID 8.846 G | Cancelled Post Market | |
| 00060976 | LACTATE CHLORIDE DEXTROSE INJ | BAXTER CORPORATION | Liquid | Intravenous | DEXTROSE 2.5 G; SODIUM LACTATE 310 MG; SODIUM CHLORIDE 300 MG | Cancelled Post Market | |
| 00039551 | LACTATED RINGER'S AND 5% DEXTROSE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 50 MG; SODIUM CHLORIDE 6 MG; POTASSIUM CHLORIDE 0.3 MG; CALCIUM CHLORIDE 0.2 MG; SODIUM LACTATE 3.1 MG | Cancelled Post Market | |
| 00478296 | LIDOCAINE 0.2% IN 5% DEXTROSE INJ | HOSPIRA HEALTHCARE ULC | Solution | Intravenous | DEXTROSE 50 MG; LIDOCAINE HYDROCHLORIDE 2 MG | Cancelled Post Market | |
| 01915479 | LIFE GUARD H E PWS | SMITHKLINE BEECHAM ANIMAL HEALTH | Powder For Solution | Oral | DEXTROSE 152 G; SODIUM BICARBONATE 12.75 G; GLYCINE 4.72 G; POTASSIUM CHLORIDE 3.6 G; SODIUM CHLORIDE 2.84 G; CALCIUM PHOSPHATE (DIBASIC) 1.33 G; MAGNESIUM SULFATE 760 MG | Cancelled Post Market | |
| 00434620 | LIFE GUARD ORAL | NORDEN LABORATORIES INC. | Powder | Oral | DEXTROSE 56.76 %; PROTEIN 18.91 %; SODIUM BICARBONATE 12.68 %; POTASSIUM CHLORIDE 3.6 %; GLYCINE 3.12 %; SODIUM CHLORIDE 2.84 %; CALCIUM PHOSPHATE (DIBASIC) 1.33 %; MAGNESIUM SULFATE .76 % | Cancelled Post Market | |
| 00568600 | LIFE PAK | VETCOM 1979 INC. | Powder For Solution | Oral | DEXTROSE 56.76 %; PROTEIN HYDROLYSATES 18.91 %; SODIUM BICARBONATE 12.68 %; POTASSIUM CHLORIDE 3.6 %; GLYCINE 3.12 %; SODIUM CHLORIDE 2.84 %; CALCIUM PHOSPHATE (TRIBASIC) 1.33 %; MAGNESIUM SULFATE .76 % | Cancelled Post Market | |
| 00725064 | LIFE-GUARD H.E. PWR | NORDEN LABORATORIES INC. | Powder | Oral | DEXTROSE 84.15 %; SODIUM BICARBONATE 7.77 %; GLYCINE 2.88 %; POTASSIUM CHLORIDE 2.2 %; SODIUM CHLORIDE 1.73 %; CALCIUM PHOSPHATE (TRIBASIC) .81 %; MAGNESIUM SULFATE .46 % | Cancelled Post Market | |
| 02009676 | LODEVIL INJECTABLE | AUSTIN, DIVISION OF VÉTOQUINOL N.-A. INC. | Liquid | Intravenous | DEXTROSE 10.8 MG; SODIUM ACETATE 4.1 MG; SODIUM BICARBONATE 4.2 MG; SODIUM CHLORIDE 3.5 MG; POTASSIUM CHLORIDE .45 MG; MAGNESIUM CHLORIDE .2 MG | Cancelled Post Market | |
| 00557943 | MONOJECT INSULIN REACTION GEL 40% | SHERWOOD MEDICAL COMPANY | Gel | Oral | DEXTROSE 40 % | Cancelled Post Market | |
| 00039489 | NORMOSOL-M & 5% DEXTROSE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 0.234 G; POTASSIUM ACETATE 0.128 G; MAGNESIUM ACETATE 0.021 G | Dormant | |
| 00039640 | NORMOSOL-R & 5% DEXTROSE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 0.526 G; SODIUM ACETATE 0.222 G; SODIUM GLUCONATE 0.502 G; POTASSIUM CHLORIDE 0.037 G; MAGNESIUM CHLORIDE 0.014 G | Dormant | |
| 02047683 | ORALYTES PCK-PWS | P.V.U., DIVISION OF VÉTOQUINOL N.-A. INC. | Package; Powder For Solution | Oral | DEXTROSE 47.562 G; SODIUM ACETATE 13.125 G; GLYCINE 6.006 G; SODIUM CHLORIDE 4.675 G; POTASSIUM PHOSPHATE DIBASIC 1.742 G; POTASSIUM CHLORIDE 1.491 G; CITRIC ACID 1 G | Cancelled Post Market | |
| 02223910 | ORALYTES-HE - PWR | P.V.U., DIVISION OF VÉTOQUINOL N.-A. INC. | Powder | Oral | DEXTROSE 152 G; SODIUM ACETATE 13.125 G; GLYCINE 6.006 G; SODIUM CHLORIDE 4.675 G; POTASSIUM PHOSPHATE DIBASIC 1.742 G; POTASSIUM CHLORIDE 1.491 G; CITRIC ACID 1 G | Cancelled Post Market | |
| 01948350 | ORALYTES-HE PWS | SANOFI SANTI ANIMALE/ANIMAL HLTH CANADA | Powder For Solution | Oral | DEXTROSE 152 G; GLYCINE 6.006 G; SODIUM ACETATE 13.125 G; SODIUM CHLORIDE 4.675 G; POTASSIUM PHOSPHATE DIBASIC 1.742 G; POTASSIUM CHLORIDE 1.491 G; CITRIC ACID 1 G | Cancelled Post Market | |
| 00260584 | PLASMA-LYTE 56 5% DEXTROSE INJ | BAXTER CORPORATION | Liquid | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 234 MG; POTASSIUM ACETATE 128 MG; MAGNESIUM ACETATE 32 MG | Cancelled Post Market | |
| 00260592 | PLASMALYTE 148 IN 5% DEXTROSE INJ | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 526 MG; SODIUM ACETATE 368 MG; SODIUM GLUCONATE 502 MG; POTASSIUM CHLORIDE 37 MG; MAGNESIUM CHLORIDE 30 MG | Cancelled Post Market | |
| 00786314 | POTAS CHLOR 20MEQ 5% DEX AND LACTATE RINGER | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 600 MG; SODIUM LACTATE 310 MG; POTASSIUM CHLORIDE 179 MG; CALCIUM CHLORIDE 20 MG | Cancelled Post Market | |
| 00786233 | POTAS CHLOR 30MEQ 5% DEX AND 0.2% SOD CHLOR | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; POTASSIUM CHLORIDE 224 MG; SODIUM CHLORIDE 200 MG | Cancelled Post Market | |
| 00786225 | POTASS CHLOR 10MEQ 5% DEX AND 0.2% SOD CHLOR | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 200 MG; POTASSIUM CHLORIDE 75 MG | Cancelled Post Market | |
| 00786268 | POTASS CHLOR 30MEQ 5% DEX AND 0.33% SOD CHLOR | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 330 MG; POTASSIUM CHLORIDE 224 MG | Cancelled Post Market | |
| 00786284 | POTASS CHLOR 30MEQ 5% DEX AND 0.45% SOD CHLOR | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 450 MG; POTASSIUM CHLORIDE 224 MG | Cancelled Post Market | |
| 00503150 | POTASS CHLOR 40MEQ 5% DEX AND 0.2% SOD CHLOR | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; POTASSIUM CHLORIDE 300 MG; SODIUM CHLORIDE 200 MG | Cancelled Post Market | |
| 00786276 | POTASS CHLOR 40MEQ 5% DEX AND 0.33% SOD CHLOR | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 330 MG; POTASSIUM CHLORIDE 300 MG | Cancelled Post Market | |
| 00786187 | POTASS CHLORIDE 10MEQ IN 5% DEXTROSE INJ USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; POTASSIUM CHLORIDE 75 MG | Cancelled Post Market | |
| 00786195 | POTASS CHLORIDE 30MEQ IN 5% DEXTROSE INJ USP | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; POTASSIUM CHLORIDE 224 MG | Cancelled Post Market | |
| 00790109 | POTASS CHLORIDE 5% DEXTR 0.45% SOD CHLOR INJ | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 450 MG; POTASSIUM CHLORIDE 75 MG | Cancelled Post Market | |
| 00786241 | POTASSIUM 20MEQ 5% DEXTROSE AND 0.33% SODIUM CHLORIDE | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 330 MG; POTASSIUM CHLORIDE 150 MG | Cancelled Post Market | |
| 00786322 | POTASSIUM CHLOR 40MEQ 5% DEX & LAC RING | BAXTER CORPORATION | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 600 MG; SODIUM LACTATE 310 MG; POTASSIUM CHLORIDE 328 MG; CALCIUM CHLORIDE 20 MG | Cancelled Post Market | |
| 00472085 | POTASSIUM CHLORIDE 20 MEQ IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 3.3 G; SODIUM CHLORIDE 0.3 G; POTASSIUM CHLORIDE 0.149 G | Dormant | |
| 00466697 | POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 5 G; POTASSIUM CHLORIDE 0.149 G | Dormant | |
| 00466689 | POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE AND 0.225% SODIUM CHLORIDE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 0.225 G; POTASSIUM CHLORIDE 0.149 G | Dormant | |
| 00466670 | POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 5 G; SODIUM CHLORIDE 0.45 G; POTASSIUM CHLORIDE 0.149 G | Dormant | |
| 00472077 | POTASSIUM CHLORIDE 40 MEQ IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 3.3 G; SODIUM CHLORIDE 0.3 G; POTASSIUM CHLORIDE 0.298 G | Cancelled Post Market | |
| 00606820 | POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 5 G; POTASSIUM CHLORIDE 0.3 G | Dormant | |
| 00603244 | POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE | ICU MEDICAL CANADA INC | Solution | Intravenous | DEXTROSE 5 G; POTASSIUM CHLORIDE 0.3 G; SODIUM CHLORIDE 0.45 G | Dormant | |
| 00137448 | PROCEPTION SPERM NUTRIENT DOUCHE | MILEX PRODUCTS LTD. | Douche | Vaginal | DEXTROSE 71 %; POTASSIUM CHLORIDE .7 %; SODIUM CHLORIDE 25.75 %; CALCIUM GLUCONATE 2.55 % | Cancelled Post Market | |
| 00763195 | REHYDRALYTE | ROSS LABORATORIES, DIVISION OF ABBOTT LABORATORIES LTD. | Liquid | Oral | DEXTROSE 25 MG; SODIUM CHLORIDE 3.8 MG; SODIUM CITRATE .78 MG; POTASSIUM CITRATE 2.04 MG | Cancelled Post Market | |
| 00859613 | REVIBE | PHIBRO ANIMAL HEALTH CORPORATION | Powder For Solution | Oral | DEXTROSE 43.238 G; SODIUM ACETATE ANHYDROUS 13.125 G; GLYCINE 6.006 G; SODIUM CHLORIDE 4.675 G; POTASSIUM PHOSPHATE DIBASIC 1.742 G; POTASSIUM CHLORIDE 1.491 G; CITRIC ACID 1 G | Dormant | |
| 00890006 | REVIBE H.E. | PHIBRO ANIMAL HEALTH CORPORATION | Powder For Solution | Oral | DEXTROSE 152 G; SODIUM ACETATE ANHYDROUS 13.125 G; GLYCINE 6.006 G; SODIUM CHLORIDE 4.675 G; POTASSIUM PHOSPHATE DIBASIC 1.742 G; POTASSIUM CHLORIDE 1.491 G; CITRIC ACID 1 G | Dormant | |
| 00701874 | SKY-LYTES | SCHUYLER LABORATORIES INC. | Powder | Oral | DEXTROSE 56.6 %; CITRIC ACID 20 %; SODIUM CHLORIDE 10 %; POTASSIUM (POTASSIUM PHOSPHATE DIBASIC) 1.74 %; COPPER (CUPRIC SULFATE) .83 %; ZINC (ZINC SULFATE) 1.18 % | Cancelled Post Market | |
| 01975455 | SPINAL ANESTHESIA TRAY | BAXTER CORPORATION | Liquid | Block/Infiltration | DEXTROSE 10 %; TETRACAINE HYDROCHLORIDE 1 %; LIDOCAINE HYDROCHLORIDE 1 % | Cancelled Post Market | |
| 00548901 | STRESS DEX | SQUIRE LABS INC. | Powder | Oral | DEXTROSE 61 %; POTASSIUM CHLORIDE 10 %; SODIUM CHLORIDE 9 %; CALCIUM PHOSPHATE (DIBASIC) 12 % | Cancelled Post Market | |
| 02359464 | STRESS-DEX | NEOGEN CORPORATION | Powder | Oral | DEXTROSE 61.0 %; POTASSIUM CHLORIDE 10.0 %; SODIUM CHLORIDE 9.0 %; CALCIUM PHOSPHATE (DIBASIC) 12.0 % | Cancelled Post Market | |
| 00260118 | SUPERDEX 50% INJ | DOMINION VETERINARY LABORATORIES LTD. | Solution | Intraperitoneal; Intravenous; Intramuscular | DEXTROSE 250 G; SODIUM CHLORIDE 4.59 G; MAGNESIUM CHLORIDE 270 MG; CALCIUM CHLORIDE 490 MG; SODIUM ACETATE 4.68 G; POTASSIUM ACETATE 900 MG; SODIUM BISULFITE 1.8 G | Dormant | |
| 02192411 | SURVIVE BRAND ENERGY PASTE FOR NEONATAL PIGLETS | BIMEDA-MTC ANIMAL HEALTH INC | Paste | Oral | DEXTROSE 16.75 %; LARD 15.46 %; COCONUT OIL 13.22 %; POTASSIUM ACETATE 11.59 %; SODIUM ACETATE 11.59 % | Dormant | |
| 02192462 | SURVIVE BRAND ENERGY PST FOR NEONATAL PIGLET | CITADEL ANIMAL HEALTH | Paste | Oral | DEXTROSE 16.75 %; LARD 15.46 %; COCONUT OIL 13.22 %; POTASSIUM ACETATE 11.59 %; SODIUM ACETATE 11.59 % | Cancelled Post Market | |
| 02003732 | TRUTOL 100 LEMON-LIME LIQ 10GM/30ML | CUSTOM LABORATORIES INC. | Liquid | Oral | DEXTROSE 10 G | Cancelled Post Market | |
| 00596639 | UNILYTE INJ | UNIVET PHARMACEUTICALS LTD. | Solution | Intraperitoneal; Intravenous | DEXTROSE 25 MG; SORBITOL 25 MG; SODIUM CHLORIDE 4.853 MG; POTASSIUM CHLORIDE 0.747 MG; MAGNESIUM CHLORIDE 0.407 MG; CALCIUM CHLORIDE .367 MG; SODIUM LACTATE 7.842 MG | Cancelled Post Market | |
| 00294349 | VITAMINACID | VETOQUINOL N A INC | Solution | Intravenous | DEXTROSE 50 MG; SODIUM ACETATE 2.5 MG; CALCIUM CHLORIDE 0.15 MG; POTASSIUM CHLORIDE 0.20 MG; MAGNESIUM SULFATE 0.20 MG; THIAMINE HYDROCHLORIDE 0.10 MG; VITAMIN B2 0.04 MG; NICOTINAMIDE 1.5 MG; DEXPANTHENOL 0.05 MG; PYRIDOXINE HYDROCHLORIDE 0.1 MG; VITAMIN B12 0.05 MCG; SODIUM GLUTAMATE 0.04 MG; CASEIN HYDROLYSATE 0.71 MG | Cancelled Post Market |
Browse other molecules: